118 related articles for article (PubMed ID: 28060337)
1. Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models.
Sciarrillo R; Wojtuszkiewicz A; Kooi IE; Gómez VE; Boggi U; Jansen G; Kaspers GJ; Cloos J; Giovannetti E
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060337
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ
Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
[TBL] [Abstract][Full Text] [Related]
3. Organ-Specific MicroRNAs (
Taniguchi K; Sugito N; Shinohara H; Kuranaga Y; Inomata Y; Komura K; Uchiyama K; Akao Y
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695138
[TBL] [Abstract][Full Text] [Related]
4. PKM1 is involved in resistance to anti-cancer drugs.
Taniguchi K; Sakai M; Sugito N; Kuranaga Y; Kumazaki M; Shinohara H; Ueda H; Futamura M; Yoshida K; Uchiyama K; Akao Y
Biochem Biophys Res Commun; 2016 Apr; 473(1):174-180. PubMed ID: 27012213
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo.
He J; Xie G; Tong J; Peng Y; Huang H; Li J; Wang N; Liang H
Cell Biochem Biophys; 2014 Nov; 70(2):1343-50. PubMed ID: 24898807
[TBL] [Abstract][Full Text] [Related]
6. Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.
Zhan C; Yan L; Wang L; Ma J; Jiang W; Zhang Y; Shi Y; Wang Q
PLoS One; 2015; 10(3):e0118663. PubMed ID: 25738776
[TBL] [Abstract][Full Text] [Related]
7. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
He Y; Wang Y; Liu H; Xu X; He S; Tang J; Huang Y; Miao X; Wu Y; Wang Q; Cheng C
Leuk Res; 2015 Dec; 39(12):1428-36. PubMed ID: 26453405
[TBL] [Abstract][Full Text] [Related]
9. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
[TBL] [Abstract][Full Text] [Related]
10. Changes in PKM2 associate with prostate cancer progression.
Wong N; Yan J; Ojo D; De Melo J; Cutz JC; Tang D
Cancer Invest; 2014 Aug; 32(7):330-8. PubMed ID: 24884829
[TBL] [Abstract][Full Text] [Related]
11. Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.
Wu M; An J; Zheng Q; Xin X; Lin Z; Li X; Li H; Lu D
Oncotarget; 2016 Oct; 7(41):66525-66539. PubMed ID: 27167190
[TBL] [Abstract][Full Text] [Related]
12. [Aberrant DNA methylation and drug resistance of tumor cells].
Xinxin S; Yujie S
Yi Chuan; 2014 May; 36(5):411-9. PubMed ID: 24846990
[TBL] [Abstract][Full Text] [Related]
13. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma.
Dayton TL; Gocheva V; Miller KM; Israelsen WJ; Bhutkar A; Clish CB; Davidson SM; Luengo A; Bronson RT; Jacks T; Vander Heiden MG
Genes Dev; 2016 May; 30(9):1020-33. PubMed ID: 27125672
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
Taniguchi K; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Ito Y; Otsuki Y; Uno B; Uchiyama K; Akao Y
Cancer Lett; 2015 Jul; 363(1):17-27. PubMed ID: 25818238
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive RNA Sequencing Analysis of the Adeno-Associated Virus (AAV) Type 2 Transcriptome Reveals Novel AAV Transcripts, Splice Variants, and Derived Proteins.
Stutika C; Gogol-Döring A; Botschen L; Mietzsch M; Weger S; Feldkamp M; Chen W; Heilbronn R
J Virol; 2016 Feb; 90(3):1278-89. PubMed ID: 26559843
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Rad51C splice variants in colorectal tumors.
Kalvala A; Gao L; Aguila B; Reese T; Otterson GA; Villalona-Calero MA; Duan W
Oncotarget; 2015 Apr; 6(11):8777-87. PubMed ID: 25669972
[TBL] [Abstract][Full Text] [Related]
17. Computational analysis of associations between alternative splicing and histone modifications.
Shindo Y; Nozaki T; Saito R; Tomita M
FEBS Lett; 2013 Mar; 587(5):516-21. PubMed ID: 23353998
[TBL] [Abstract][Full Text] [Related]
18. Expression profile analysis of long non-coding RNA associated with vincristine resistance in colon cancer cells by next-generation sequencing.
Sun QL; Zhao CP; Wang TY; Hao XB; Wang XY; Zhang X; Li YC
Gene; 2015 Nov; 572(1):79-86. PubMed ID: 26164760
[TBL] [Abstract][Full Text] [Related]
19. Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression.
Wei L; Dai Y; Zhou Y; He Z; Yao J; Zhao L; Guo Q; Yang L
Cell Death Dis; 2017 Jul; 8(7):e2944. PubMed ID: 28726775
[TBL] [Abstract][Full Text] [Related]
20. Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer.
Griffith M; Mwenifumbo JC; Cheung PY; Paul JE; Pugh TJ; Tang MJ; Chittaranjan S; Morin RD; Asano JK; Ally AA; Miao L; Lee A; Chan SY; Taylor G; Severson T; Hou YC; Griffith OL; Cheng GS; Novik K; Moore R; Luk M; Owen D; Brown CJ; Morin GB; Gill S; Tai IT; Marra MA
Pharmacogenomics J; 2013 Apr; 13(2):148-58. PubMed ID: 22249354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
